Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
This research does not provide a peptide treatment but rather identifies a peptide pathway that could be targeted to reduce eczema-associated itch, potentially through BNP receptor antagonists
Common Contraindications Active or recent cancer (BPC-157 and TB-500 angiogenesis concern), Wilson's disease or other copper metabolism disorders (GHK-Cu component), pregnancy or breastfeeding (no safety data for any component), and competitive sport at WADA-tested levels (BPC-157 and TB-500 are listed under WADA category S0 Unapproved Substances) are commonly cited reasons not to research KLOW
doi:10.1186/s12974-024-03033-7 44
Pro tip: Works best alongside anti-inflammatory foods (like omega-3s, leafy greens) and consistent resistance training that enhances insulin sensitivity
US$ 27.48
US$ 26.16
US$ 25.09
US$ 27.58
US$ 28.99
US$ 29.40
US$ 24.32
US$ 29.34
US$ 22.44
US$ 21.82
.webp)
US$ 23.23
US$ 20.60
US$ 28.19
